Searched for
FAVIPIRAVIR
Hantavirus: Britain secures experimental Japanese drug to strengthen responseBritain has received experimental favipiravir from Japan to treat a deadly hantavirus outbreak. The drug is not licensed in the UK and its ...- Glenmark concludes study on COVID drug FavipiravirResults showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects like weakness, gastritis, diar...
- Bharat Parenterals gets DCGI nod for favipiravir oral suspensionThe company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parente...
- Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
- COVID-19: Favipiravir shows hope in Mumbai trialWhile the WHO last week recommended that antiviral remdesivir not be used for severely ill Covid-19 patients, Mumbai doctors published the ...
- No 'significant' benefit of favipiravir, umifenovir combination in Covid treatment: GlenmarkGlenmark had in May intimated the study to examine whether early administration of a combination of Favipiravir and Umifenovir enhances ant...
- After tablets, Hetero working on antiviral medicine Favipiravir injectionsIf successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...
- Favipiravir fastest molecule to cross Rs 100 crFavipiravir, a drug used in the treatment of Covid-19 patients with mild symptoms, became the largest-selling medicine in India in Septembe...
- BDR Pharma to launch 400mg Favipiravir tablets for treating coronavirus patients in IndiaThe company had received approval from the Drugs Controller General of India (DCGI) to manufacture Favipiravir to treat patients with mild ...
- Hyderabad pharmaceutical Raghava Life Sciences gets nod to make Favipiravir APIThe Hyderabad-based producer of active pharmaceutical ingredients (APIs) had in May commercialised the Favipiravir API and is currently dis...
- Sun Pharma latest to sell COVID-19 drug favipiravir in India, to cost Rs 35 per tabletFavipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in ...
- Trial results show significant faster time to clinical improvement with Favipiravir: GlenmarkResults from the Phase 3 trial showed numerical improvements for the primary efficacy endpoint with 28.6 per cent faster viral clearance in...
- Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...
- Drug firms get DGCI nod for Covid drug favipiravir despite inconclusive studyOn Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...
- Hyderabad based Biophore India gets DCGI nod to manufacture COVID drug FavipiravirFavipiravir is an antiviral agent that was initially discovered and developed because of its activity against another RNA (ribonucleic acid...
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...
- Raghava Life Sciences in talks with formulators for potential Covid drug FavipiravirFavipiravir, a generic version of Avigan that is used to treat influenza in Japan, is being studied as an experimental drug in treating the...
- Russia enters final stage of clinical trial of drug to treat Covid patientsRussian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group on Friday announced the start of the final stage o...
- Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patientsThe Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...
- Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatmentStrides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...
Load More
